Visual Analysis of Immuno-Oncology Market Clinical Trials Review 2017 – Pipeline Products by Stage of Development
Oct 9, 2017
WiseGuyReports.com adds Exclusive Research on “Visual Analysis of Immuno-Oncology Market ” reports to its database.
PUNE, INDIA - October 9, 2017 /MarketersMedia/ —
SUMMARY
WiseGuyReports published new report, titled “Visual Analysis of Immuno-Oncology Development and Opportunities”
Immuno-Oncology (IO) is uniquely positioned to become the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and other targeted treatments. In order to assist our clients with navigating the burgeoning amount information arising as a result of the rapidly growing field of IO clinical research, GlobalData is offering a comprehensive analysis of both pipeline and marketed active immunity IO therapies.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2368370-pharmafocus-visual-analysis-of-immuno-oncology-development-and-opportunities
Key Topics Covered –
- Immune Checkpoint Modulators - Trends in Clinical Trial Development
- Competitive Assessment of Marketed PD-(L)1 Checkpoint Modulators
- Emergence of New Immune Checkpoint Targets
- Clinical and Commercial Opportunities for Highly Anticipated CAR Cell Therapies
- Cell Vaccines: Steady Development Stimulated by Prior IO Success
- Promising IO-IO Combinations Utilizing Oncolytic Viruses
Key points to buy
- The PharmaFocus consists of a highly-visual slide deck that is intended to facilitate the dissemination of aggregated data and insights from analyses of over 800 IO products that are either marketed or in Phase I-III of clinical development.
- Types of graphical analyses include - Cumulative Plots, Aggregated Bubble Plots, Pie Charts, Matrix Analyses
- Unique, actionable insights applicable to IO drugs in five major categories: Immune Checkpoint Modulators, Cellular Immunotherapies, Oncolytic Viruses, Peptide Vaccines, and Bispecific T-Cell Engagers are provided in this report.
- Analysis of over 4000 clinical trials enrolling patients with 18 solid tumors and eight hematological cancers are included.
Table of Contents
1. Preface
2. Immuno-Oncology Product Definition and Classification
3. Recent Timeline of Immuno-Oncology Approvals
4. Immune Checkpoint Modulators - Trends in Clinical Trial Development
5. Competitive Assessment of Marketed PD-(L)1 Checkpoint Modulators
6. Emergence of New Immune Checkpoint Targets
7. Cellular Immunotherapies in Clinical Development
8. Clinical and Commercial Opportunities for Highly Anticipated CAR Cell Therapies
9. Cell Vaccines: Steady Development Stimulated by Prior IO Success
10. T-cell Redirecting Therapies: Comparison Between CAR Cell Therapies and Bispecific T-Cell Engager Antibodies
11. Promising IO-IO Combinations Utilizing Oncolytic Viruses
12. Appendix
..CONTINUED
About Us
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: wiseguyreports
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349
For more information, please visit https://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 247091
More News
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.